Ignite Creation Date:
2024-05-06 @ 4:03 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04858958
Status:
RECRUITING
Last Update Posted:
2023-01-18
First Post:
2021-04-12
Brief Title:
Study of FURMONERTINIB in Patients With NSCLC Having Exon 20 Insertion Mutation
Sponsor:
Allist Pharmaceuticals Inc
Organization:
Allist Pharmaceuticals Inc
Organization Data
Organization:
Allist Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
Protocol No ALSC012AST2818
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Allist Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None